Informações:
Falhas:
ID
20416
Descrição
Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00536939
Link
https://clinicaltrials.gov/show/NCT00536939
Palavras-chave
Versões (1)
- 22/02/2017 22/02/2017 -
Transferido a
22 de fevereiro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Breast Cancer NCT00536939
Eligibility Breast Cancer NCT00536939
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00536939
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
informed consent
Item
must have signed an inform consent document
boolean
C0021430 (UMLS CUI [1])
Breast Carcinoma; histological diagnosis; Cancer diagnosis based on cytological evidence | Unresectable Malignant Neoplasm | Recurrent disease | Metastatic Neoplasm
Item
have histologic or cytologic diagnosis of breast cancer with evidence of unresectable locally recurrent or metastatic disease
boolean
C0678222 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
C1298647 (UMLS CUI [1,3])
C1336869 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C2939420 (UMLS CUI [4])
C0679557 (UMLS CUI [1,2])
C1298647 (UMLS CUI [1,3])
C1336869 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
C2939420 (UMLS CUI [4])
Prior Chemotherapy | Locally Recurrent Malignant Neoplasm | Metastatic Neoplasm
Item
have not received any prior chemotherapy for locally recurrent or metastatic disease
boolean
C1514457 (UMLS CUI [1])
C2986682 (UMLS CUI [2])
C2939420 (UMLS CUI [3])
C2986682 (UMLS CUI [2])
C2939420 (UMLS CUI [3])
adjuvant or neoadjuvant taxane therapy
Item
have not had adjuvant or neoadjuvant taxane therapy within 12 months prior to assignment to study treatment
boolean
C3541958 (UMLS CUI [1,1])
C0600558 (UMLS CUI [1,2])
C0677850 (UMLS CUI [1,3])
C1514457 (UMLS CUI [1,4])
C0600558 (UMLS CUI [1,2])
C0677850 (UMLS CUI [1,3])
C1514457 (UMLS CUI [1,4])
age, informed consent
Item
age 18 years or older at time of informed consent
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])
cns metastases
Item
have any clinical evidence of central nervous system (cns) metastases
boolean
C0686377 (UMLS CUI [1])
have a history of seizure
Item
have a history of seizure
boolean
C0036572 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0262926 (UMLS CUI [1,2])
surgical procedure
Item
have had a major surgical procedure within 4 weeks prior to assignment to study treatment
boolean
C0543467 (UMLS CUI [1])
Minor Surgical Procedures | Vascular Access Device Placement | Fine needle aspiration biopsy
Item
have had a minor surgical procedure, placement of an access device, or fine needle aspiration within 7 days prior to assignment to study treatment
boolean
C0038904 (UMLS CUI [1])
C1519955 (UMLS CUI [2])
C1510483 (UMLS CUI [3])
C1519955 (UMLS CUI [2])
C1510483 (UMLS CUI [3])
symptomatic peripheral vascular disease
Item
have symptomatic peripheral vascular disease
boolean
C0085096 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,2])